FDA Nanotechnology Report Outlines Scientific, Regulatory Challenges
July 30th, 2007 by 
Barry - Admin BioPharmArena
The U.S. Food and Drug Administration (FDA)’s Nanotechnology Task Force released a report that recommends the agency consider developing guidance and taking other steps to address the benefits and risks of drugs and medical devices using nanotechnology.
“Nanotechnology holds enormous potential for use in a vast array of products,” said Commissioner of Food and Drugs Andrew von Eschenbach, M.D., who endorsed the Task Force Report and its recommendations on July 23, 2007. “Recognizing the emerging nature of this technology and its potential for rapid development, this report fosters the continued development of innovative, safe and effective FDA-regulated products that use nanotechnology materials.
Posted in News, Regulatory Affairs | 